T1	OrganismPart 81 95	Red Blood Cell
T2	Disease 96 140	Invasion by Plasmodium falciparum Merozoites
T3	OrganismPart 159 162	RBC
T4	OrganismPart 143 157	Red blood cell
*	Equiv T4 T3
T5	Disease 276 300	P. falciparum merozoites
T6	Organism 45916 45939	P. falciparum merozoite
T7	CleavageAgent 47425 47432	trypsin
T8	Label 47547 47557	label-free
T9	FractionationMethod 47688 47700	Ion-exchange
T10	FractionationMethod 47807 47829	strong cation exchange
T11	FractionationMethod 47831 47834	SCX
*	Equiv T10 T11
T12	Label 48036 48051	Tandem mass tag
T13	Label 48053 48056	TMT
T14	FractionationMethod 48091 48136	hydrophilic interaction liquid chromatography
T15	FractionationMethod 48138 48143	HILIC
*	Equiv T14 T15
*	Equiv T12 T13
T16	CleavageAgent 48228 48235	trypsin
T17	Label 48303 48306	128
T18	Label 48308 48311	129
T19	Label 48317 48320	130
T20	NumberOfFractions 47911 47919	12 to 15
T21	NumberOfFractions 48466 48474	12 to 15
T22	Strain 45965 45968	3D7
T23	FragmentationMethod 50193 50229	high-energy collisional dissociation
T24	FragmentationMethod 50231 50234	HCD
T25	Modification 50740 50773	carbamidomethylation of cysteines
A1	Modification T25 fixed
T26	Modification 50807 50830	oxidation of methionine
T27	Modification 50832 50862	protein N-terminal acetylation
T28	Modification 50868 50915	serine/threonine/tyrosine (STY) phosphorylation
A2	Modification T26 variable
A3	Modification T27 variable
A4	Modification T28 variable
T29	Experiment 50389 50392	TMT
T30	Experiment 50397 50407	label-free
T31	PrecursorMassTolerance 51000 51006	20 ppm
T32	FragmentMassTolerance 51011 51017	0.5 Da
T33	CellType 46080 46089	schizonts
T34	Treatment 46305 46314	IC buffer
T35	Treatment 46316 46325	EC buffer
T36	Treatment 46419 46431	EC-BA buffer
T37	Treatment 47279 47281	IC
T38	Treatment 47284 47286	EC
T39	Treatment 47293 47298	EC-BA
